Dateline City: DURHAM, N.C. & Paris Tryton Stent Consistently Demonstrates Excellent Results Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced results from the company’s TRYTON Side Branch Stent™ System presented during a Trytonsponsored symposium in conjunction with the EuroPCR 2010 conference in Paris. Robert-Jan Van Geuns, M.D., senior cardiologist at Erasmus Medical …
Tryton Announces Enrollment Completion of Two European Registries
Dateline City: RESEARCH TRIANGLE PARK, N.C. Studies Will Assess Tryton Side-Branch Stent in Real-World Settings More than 1,000 Patients Treated with Tryton System RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced completion of enrollment in E-Tryton 150 and E-Tryton Benelux, two European registry studies of the company’s TRYTON …
Tryton Stent Implanted in First Cases in Portugal and Austria
Dateline City: DURHAM, N.C. Company Celebrates 750th Implant DURHAM, N.C.–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the Tryton® stent has been implanted for the first time in Portugal and Austria. Francisco Pereira Machado, M.D., of Hospital da Luz in Lisbon performed the first implant in Portugal. “The Tryton Side …
Tryton Announces Events at European Bifurcation Club Meeting
Dateline City: DURHAM, N.C. Leading Cardiologists will Discuss Experience with Tryton Stent System DURHAM, N.C.–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the company’s TRYTON Side Branch Stent™ System will be featured in discussions by a number of leading cardiologists in a symposium on Oct. 16, 2009, in conjunction with …
Tryton Medical, Inc. Broadcasts Successful Live Case Using Company’s Side Branch Stent™ to Definitively Treat Bifurcation Lesions at TCT 2009
Dateline City: DURHAM, N.C. & San Francisco More than 1,000 Clinicians Observe Implantation of Unique Stent System for Difficult-to-Treat Coronary Artery Disease DURHAM, N.C. & San Francisco–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced today the transmission of a live satellite feed of a clinical case performed in the United Kingdom to …
Tryton Awarded Patent for Innovative Side Branch Stent System
Dateline City: DURHAM, N.C. Patent Award Recognizes Unique Technology DURHAM, N.C.–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced today that a U.S. patent has been awarded for the company’s Tryton Side Branch Stent™ System. The Tryton Side Branch Stent offers a dedicated strategy for treating atherosclerotic lesions at a bifurcation. These lesions …
J. Greg Davis Appointed President & Chief Executive Officer of Tryton Medical, Inc.
Dateline City: RESEARCH TRIANGLE PARK, N.C. RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Tryton Medical, Inc. announced today that it has appointed J. Greg Davis as President and Chief Executive Officer. Founded in 2003, Tryton Medical is the leading developer of stents that are designed to definitively treat bifurcation lesions. Mr. Davis joins Tryton Medical after a successful 20-year career with Guidant and …
Tryton Medical’s Side-Branch Stent Demonstrates Unparalleled Ease-of-Use to Definitively Treat Wide Variety of Extremely Challenging Bifurcated Lesions at EuroPCR 2007
Dateline City: NEWTON, Mass. Thousands of Leading Interventional Cardiologists Witness New Paradigm Shift in Cardiology Procedures NEWTON, Mass.–(BUSINESS WIRE)–Tryton Medical, Inc., announced it successfully treated extremely challenging cases at EuroPCR 2007 in Barcelona, Spain to demonstrate how the firm’s Side-Branch Stent will ultimately reshape the treatment of bifurcated lesions. EuroPCR provided an important informational venue that enabled thousands of interventional …
Tryton Medical’s Side-Branch Stent™ Demonstrates Unparalleled Ease-of-Use and Definitive Treatment of Bifurcation Lesions at TCT Asia 2007 and at the American College of Cardiology’s Innovation and Intervention (i2) Summit in New Orleans
Dateline City: NEWTON, Mass. Interventional Cardiologists Treat Complex Lesions Within 10 Minutes, With Superb Angiographic Results NEWTON, Mass.–(BUSINESS WIRE)–Tryton Medical, Inc. has marked new milestones in stent technology by demonstrating on a global scale how the firm’s Side-Branch Stent offers unparalleled ease-of-use and the best option to safely and definitively treat bifurcation lesions. Tryton transmitted a live satellite feed of …
Tryton Medical, Inc. Broadcasts Successful Live Case Using Company’s Side-Branch Stent™ to Definitively Treat Bifurcation Lesions in Front of 1,000 Cardiologists at JIM 2007 Conference in Rome
Dateline City: NEWTON, Mass. NEWTON, Mass.–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, announced that it transmitted a live satellite feed of a clinical case, which was performed at the Helios Heart Center in Siegburg Germany, to an audience of over 1,000 interventional cardiologists at the Joint Interventional Meeting (JIM 2007) in Rome. The …